Results 211 to 220 of about 333,388 (343)

Prevalence and comparison of severity of disease and complications among patients with night-time dyspnea in chronic obstructive pulmonary disease to those without night-time dyspnea

, 2023
V. Deepan, D Dhanalakshmi, G Sravan Kumar, Tarun Kumar   +3 more
openalex   +1 more source

Respiratory Syncytial Virus (RSV): A Comprehensive Overview From Basic Biology to Clinical Prevention and Control

Medicinal Research Reviews, EarlyView.
ABSTRACT Respiratory syncytial virus (RSV) is a common virus that causes respiratory infections, posing a serious threat, particularly to infants, the elderly, and individuals with compromised immune systems. As the leading cause of lower respiratory tract infections (LRTIs) in infants, RSV is responsible for millions of cases worldwide each year.
Jie Shi, Xiya Huang, Chunjun Ye, Yishan Lu, Yanyan Liu, Yuquan Wei, Xiawei Wei   +6 more
wiley   +1 more source

A Rare Cause of Dyspnea in a Patient with Multiple Myeloma: Tracheobronchial Amyloidosis

Turkish Journal of Hematology
Furkan Ufuk, İclal Ocak
doaj   +1 more source

Efficacy of modified versus standard Valsalva maneuvers on clinical outcomes and satisfaction of children with paroxysmal supraventricular tachycardia: randomized control trial. [PDF]

BMC Pediatr
Magor NRE, Elhalafawy SEH, Ads SEM, Abdelfattah ME, Melika SWM.   +4 more
europepmc   +1 more source

Dynamic RBC‐To‐Membrane Ratio in 129Xe MRI: A Biomarker of Decreased Lung Function in Pulmonary and Vascular Diseases

Magnetic Resonance in Medicine, EarlyView.
ABSTRACT Purpose To present a method for quantifying dissolved 129Xe spectroscopy using singular value decomposition (SVD) and a dynamic red blood cell (RBC)/membrane ratio as a biomarker of disease. Methods A spectroscopic sequence was performed in 45 subjects (27 healthy, 12 dyspnea of unknown origin [DUO], and 6 pulmonary hypertension [PH ...
Gabriela María García Delgado, Ummul Afia Shammi, Cody Thornburgh, Mia Ruppel, Isabella Parks, Aaron Miller, John P. Mugler III, Talissa A. Altes, Robert P. Thomen   +8 more
wiley   +1 more source

Factors associated with the effectiveness of opioids for dyspnea in hospitalized patients with heart failure: a retrospective, multicenter, observational study. [PDF]

J Pharm Health Care Sci
Yoshikai S, Moriya Y, Yamada T, Higuchi J, Goto E, Nishihara M, Ashida A, Ikeda K.   +7 more
europepmc   +1 more source

Exertional Dyspnea Comparison in Four Maximal Training Exercises used in Pulmonary Rehabilitation: Continuous versus Bi-Level Responses in Time

, 2017
Miguel Blasco Giménez, Pedro Saavedra
openalex   +1 more source

An Elderly Woman With Dyspnea [PDF]

, 2015
Jeremy O’Connor, Demetra S Gibson
openalex   +1 more source

Phase 3b Extension Study MT‐1186‐A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral Sclerosis

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims An On/Off dosing regimen of intravenous (IV) edaravone and edaravone oral suspension is currently approved in the US for treatment of amyotrophic lateral sclerosis (ALS). Placebo‐controlled clinical trials showed that IV edaravone slows physical functional decline.
Angela Genge, Jeffrey Rothstein, Shari De Silva, Lorne Zinman, Marvin Chum, Adriano Chiò, Gen Sobue, Masashi Aoki, Hiide Yoshino, Manabu Doyu, Daniel Selness, Vesna Todorovic, Manabu Hirai, Nissim Sasson, Fumihiro Takahashi, Michelle Cecić, Art Wamil, Stephen Apple   +17 more
wiley   +1 more source

Obstructive fibrinous tracheal pseudomembrane in a hemodialysis patient: a case report and review of literature. [PDF]

BMC Nephrol
Hou J, Li H, Niu F, Mu X, Zhang S, Huang L, Cai Z.   +6 more
europepmc   +1 more source